A College of Biomedical and Life Sciences Next Generation Sequencing Showcase
15th September 2017, 09:00-14:00, Cardiff University: venue to be confirmed
The College of Biomedical and Life Sciences (CBLS) at Cardiff University contains a vibrant community of researchers using next-generation and 3rd-generation DNA sequencing technologies (NGS and 3rdGS) to tackle cutting-edge projects ranging from ecology to medical diagnostics. Necessarily, our sequencing platforms and labs are spread across campuses, but this sometimes makes communication and collaboration difficult. Open to all in CBLS to attend, this half-day event aims to bring our community together to showcase and share the breadth of our technical expertise and science.
The meeting will consist of a series of 10 minute talks from groups using NGS and 3rdGS technologies. Presentations will follow a common format, which will cover: the technology being used, the research findings and the impact of the work. Each abstract and presentation should include the following sub-sections:
- A short description of a core sequencing/genomics workflow in which a group specialises
- A brief description of the sequencer platforms used
- Highlights of a significant research result or impact derived from the work
This format will allow the user community to appreciate the depth and breadth of the fantastic science that we produce using sequencing technologies, and identify areas of expertise across the College, thus promoting collaboration and support. The organisers will include as many presentations as possible. If we are oversubscribed, we will timetable presentations covering the widest selection of methodology and subject areas and will offer poster space to any groups not selected. Lunch and refreshments provided.
This event is free to attend but please register via Eventbrite: http://ow.ly/hTx930dlG2t
Abstracts (structured to include the 3 sub-sections above and no more than 200 words in length) should be submitted to email@example.com by 1st September 2017
This event is supported by Cardiff University College of Biomedical and Life Sciences and New England BioLabs Inc.